CenturyLink Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

CenturyLink Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-633	Closed	-$99K	–	300
2015 Q3	$99K	Sell	633 -921	-59%	-$168K	0.03%	238
2015 Q2	$281K	Sell	1,554 -824	-35%	-$142K	0.09%	213
2015 Q1	$412K	Sell	2,378 -1,123	-32%	-$203K	0.14%	192
2014 Q4	$648K	Sell	3,501 -3,192	-48%	-$591K	0.19%	160
2014 Q3	$1.11M	Buy	6,693 +4,411	+193%	+$724K	0.38%	112
2014 Q2	$357K	Buy	+2,282	New	+$360K	0.11%	196

Other funds holding ALXN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CenturyLink Investment Management's ALXN Position: Q4 2015 in Review

CenturyLink Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q4 2015, closing a stake of 633 shares — an estimated $99K sold.

CenturyLink Investment Management first reported a position in ALXN in Q2 2014 and held it in 6 quarters. The position peaked at $1.11M in Q3 2014. 548 funds tracked by Wall St. Rank hold ALXN as of Q4 2015.

CenturyLink Investment Management reported no remaining Alexion Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
CenturyLink Investment Management sold 633 Alexion Pharmaceuticals shares in Q4 2015, an estimated $99K.
CenturyLink Investment Management first reported a position in Alexion Pharmaceuticals in Q2 2014 and held it in 6 quarters.
CenturyLink Investment Management's Alexion Pharmaceuticals position peaked at $1.11M in Q3 2014.
548 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2015.

Based on CenturyLink Investment Management's 13F filing for Q4 2015, filed 25 Jan 2016.